Aldose reductase has been implicated in the etiology of many diabetic complications including cataract, retinopathy, nephropathy, and neuropathy. The long-term objective of the proposed research is to identify molecular parameters which regulate the genetic expression of this important enzyme. Research effort will focus on three levels of human aldose reductase gene expression: 1) Isolation and characterization of aldose reductase mRNA, 2) molecular cloning and sequencing of the aldose reductase gene, and 3) analysis of aldose reductase gene expression in various normal and diabetic human tissues. 1) Aldose reductase mRNA will be isolated by affinity and immunological methods and characterized with respect to molecular size, translational efficiency under various conditions, and post-transcriptional modifications. 2) The structural and functional organization of the aldose reductase gene system will be determined through molecular cloning studies. Aldose reductase ds cDNA will be cloned into homopolymer-tailed plasmid vectors and also cloned into plasmid expression vectors. Human aldose reductase genomic DNA will be cloned into bacteriophage expression vectors. Recombinant expression vector libraries will be screened by newly developed immunological procedures. The DNA sequence of appropriate recombiant clones will be determined by chemical and/or dideoxy chain termination methods. The functional organization of aldose reductase genomic DNA will be analyzed for possible regulatory elements; promotor sequences, initiation sites for transcription and translation, mRNA splice sites and polyadenylation signal, and termination sites for translation. The aldose reductase amino acid sequence will be deduced from cloned cDNA and genomic DNA sequences. 3. The level of aldose reductase gene expression in normal and diabetic tissues will be studied at the mRNA and protein levels. Dot blot and Northern hybridization will be used to quantitate and characterize tissue-specific aldose reductase mRNA. Aldose reductase gene translation products will be determined by immunological methods as well as by enzyme kinetic analysis. Aldose reductase gene expression in tissue culture will be explored.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Unknown (R23)
Project #
1R23EY005856-01
Application #
3447788
Study Section
Visual Sciences A Study Section (VISA)
Project Start
1984-12-01
Project End
1987-11-30
Budget Start
1984-12-01
Budget End
1985-11-30
Support Year
1
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Emory University
Department
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Chang, Kun-Che; Shieh, Biehuoy; Petrash, J Mark (2016) Aldose reductase mediates retinal microglia activation. Biochem Biophys Res Commun 473:565-71
Nagaraj, Ram H; Nahomi, Rooban B; Mueller, Niklaus H et al. (2016) Therapeutic potential of ?-crystallin. Biochim Biophys Acta 1860:252-7
Chang, Kun-Che; Petrash, J Mark (2015) Aldose Reductase Mediates Transforming Growth Factor ?2 (TGF-?2)-Induced Migration and Epithelial-To-Mesenchymal Transition of Lens-Derived Epithelial Cells. Invest Ophthalmol Vis Sci 56:4198-210
Snow, Anson; Shieh, Biehuoy; Chang, Kun-Che et al. (2015) Aldose reductase expression as a risk factor for cataract. Chem Biol Interact 234:247-53
Chang, Kun-Che; Snow, Anson; LaBarbera, Daniel V et al. (2015) Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells. Chem Biol Interact 234:254-60
Li, Linfeng; Chang, Kun-Che; Zhou, Yaming et al. (2014) Design of an amide N-glycoside derivative of ?-glucogallin: a stable, potent, and specific inhibitor of aldose reductase. J Med Chem 57:71-7
Chang, Kun-Che; Ponder, Jessica; Labarbera, Daniel V et al. (2014) Aldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microglia. Invest Ophthalmol Vis Sci 55:2853-61
Chang, Kun-Che; Laffin, Brian; Ponder, Jessica et al. (2013) Beta-glucogallin reduces the expression of lipopolysaccharide-induced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissues. Chem Biol Interact 202:283-7
Petrash, J Mark (2013) Aging and age-related diseases of the ocular lens and vitreous body. Invest Ophthalmol Vis Sci 54:ORSF54-9
Puppala, Muthenna; Ponder, Jessica; Suryanarayana, Palla et al. (2012) The isolation and characterization of ýý-glucogallin as a novel aldose reductase inhibitor from Emblica officinalis. PLoS One 7:e31399

Showing the most recent 10 out of 16 publications